论文部分内容阅读
芬兰研究人员发现,高水平抗心磷脂抗体(aCLA)可能是心肌梗塞或心脏病发作的预测指标.他们发现,133名五年内有心脏病发作者的aCLA水平高于133名无心脏病发作者.这些观察对象在开始进行研究时均无冠状动脉疾病,但有高水平低密度脂蛋白(LDL)(≥5.2mmol/L).
Finnish researchers found that a high level of anticardiolipin antibodies (aCLA) may be a predictor of myocardial infarction or heart attack and found that 133 aCLA patients with a heart attack within five years were higher than 133 without a heart attack. These subjects did not have coronary artery disease at the start of the study, but had high levels of low-density lipoprotein (LDL) (≥ 5.2 mmol / L).